MedPath

Effect of zinc supplementation in treatment of pregnant women at risk for intrauterine growth restrictio

Phase 3
Conditions
Pregnancy.
Sequelae of complication of pregnancy, childbirth and the puerperium
Registration Number
IRCT20170513033941N33
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Pregnant women at risk for intrauterine growth restriction.
Individuals aged 18 to 40 years.

Exclusion Criteria

The consumption of zinc supplements throughout past 3 months
Hyper- and hypothyroidism
Urinary tract infection
Smoking
Having liver or kidney diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total antioxidant. Timepoint: At the beginning of the study and after 10 weeks of intervention. Method of measurement: Spectrophotometry.;Pulsatility index. Timepoint: At the beginning of the study and after 10 weeks of intervention. Method of measurement: Sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath